Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD
出版年份 2021 全文链接
标题
Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD
作者
关键词
Cardiovascular event, Chronic kidney disease, Kidney outcome, Low-density lipoprotein cholesterol, Mortality
出版物
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 32, Issue 2, Pages 410-419
出版商
Elsevier BV
发表日期
2021-10-14
DOI
10.1016/j.numecd.2021.09.037
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Indoxyl Sulfate, a Uremic Endotheliotoxin
- (2020) Guillaume Lano et al. Toxins
- Longitudinal Lipid Trends and Adverse Outcomes in Patients with Chronic Kidney Disease: A 13-Year Observational Cohort Study Using Registry-Based Electronic Medical Records
- (2019) Ching-Wei Tsai et al. JOURNAL OF LIPID RESEARCH
- Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
- (2019) Archna Bajaj et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease
- (2019) Frida Emanuelsson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
- (2018) Karen A. Hicks et al. CIRCULATION
- Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease
- (2018) Julio A Lamprea-Montealegre et al. HEART
- Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study
- (2018) Richard L. Amdur et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Lipid management in patients with chronic kidney disease
- (2018) Charles J. Ferro et al. Nature Reviews Nephrology
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
- (2016) Nans Florens et al. Toxins
- Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population
- (2016) Michael Thompson et al. Journal of Clinical Medicine
- Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Effects of Lowering LDL Cholesterol on Progression of Kidney Disease
- (2014) R. Haynes et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods
- (2014) Kook-Hwan Oh et al. BMC Nephrology
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: A meta-analysis of prospective cohort studies
- (2013) Yujie Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Association between LDL-C and Risk of Myocardial Infarction in CKD
- (2013) M. Tonelli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial
- (2010) Robert G. Fassett et al. ATHEROSCLEROSIS
- Hyperlipidemia and Long-Term Outcomes in Nondiabetic Chronic Kidney Disease
- (2010) V. Chawla et al. Clinical Journal of the American Society of Nephrology
- Receiver Operating Characteristic Curve in Diagnostic Test Assessment
- (2010) Jayawant N. Mandrekar Journal of Thoracic Oncology
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of simvastatin on kidney function loss in patients with coronary heart disease
- (2008) Janna Huskey et al. ATHEROSCLEROSIS
- Survival analysis: time-dependent effects and time-varying risk factors
- (2008) Friedo W. Dekker et al. KIDNEY INTERNATIONAL
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More